Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.

@article{Villemagne2011AmyloidIW,
  title={Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.},
  author={Victor Villemagne and Kevin Ong and Rachel S. Mulligan and Gerhard Holl and Svetlana Pejoska and Gareth Jones and Graeme O'Keefe and Uwe Ackerman and Henri Jacques Tochon-Danguy and J. Gordon Chan and Cornelia Reininger and Lueder M. Fels and Barbara Putz and Beate Rohde and Colin L. Masters and Christopher C. Rowe},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2011},
  volume={52 8},
  pages={1210-7}
}
UNLABELLED Amyloid imaging with (18)F-labeled radiotracers will allow widespread use, facilitating research, diagnosis, and therapeutic development for Alzheimer disease. The purpose of the study program was to compare cortical amyloid deposition using (18)F-florbetaben and PET in controls and subjects with mild cognitive impairment (MCI), frontotemporal lobar degeneration (FTLD), dementia with Lewy bodies (DLB), vascular dementia (VaD), Parkinson disease (PD), and Alzheimer disease (AD… CONTINUE READING
Highly Influential
This paper has highly influenced 12 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 15 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 107 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Similar Papers

Loading similar papers…